{"data":[{"accessionNo":"0001214659-26-012604","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-06","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":4814700,"percentOfClass":6,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001214659-26-012604","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-06","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":4814700,"percentOfClass":6,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001214659-26-012604","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-06","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":2488519,"percentOfClass":3.1,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001214659-26-012604","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-06","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":1665077,"percentOfClass":2.1,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001214659-26-012604","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-06","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":661104,"percentOfClass":0.8,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001214659-26-012604","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-06","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0000315066-26-001112","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001593899","issuerName":"ATEA PHARMACEUTICALS INC","ticker":"AVIR","cusip":"04683R106","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":11950771.87,"percentOfClass":15,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0000315066-26-001112","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001593899","issuerName":"ATEA PHARMACEUTICALS INC","ticker":"AVIR","cusip":"04683R106","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":11950771.87,"percentOfClass":15,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0000102909-26-000786","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals Inc","ticker":"AVIR","cusip":"04683R106","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001373604-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Leonard Braden Michael","reportingCik":null,"personType":"IN","sharesOwned":7810000,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0001373604-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001593899","issuerName":"Atea Pharmaceuticals, Inc.","ticker":"AVIR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BML Investment Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":7490000,"percentOfClass":9.6,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0000315066-25-002957","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001593899","issuerName":"ATEA PHARMACEUTICALS INC","ticker":"AVIR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-11-28","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9095679.87,"percentOfClass":11.6,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/avir"},{"accessionNo":"0000315066-25-002957","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001593899","issuerName":"ATEA PHARMACEUTICALS INC","ticker":"AVIR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-11-28","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9095679.87,"percentOfClass":11.6,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/avir"}],"updatedAt":"2026-11-05T11:35:21.616Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/avir","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}